{"name":"Capricor Inc.","slug":"capricor-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CAP-1002","genericName":"CAP-1002","slug":"cap-1002","indication":"Duchenne muscular dystrophy (DMD) with cardiac involvement","status":"phase_2"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Deramiocel (CAP-1002)","genericName":"Deramiocel (CAP-1002)","slug":"deramiocel-cap-1002","indication":"Acute myocardial infarction with reduced ejection fraction","status":"phase_3"}]}],"pipeline":[{"name":"CAP-1002","genericName":"CAP-1002","slug":"cap-1002","phase":"phase_2","mechanism":"CAP-1002 is an allogeneic cardiosphere-derived cell therapy that promotes cardiac repair and regeneration through paracrine signaling and immunomodulation.","indications":["Duchenne muscular dystrophy (DMD) with cardiac involvement","Acute myocarditis"],"catalyst":""},{"name":"Deramiocel (CAP-1002)","genericName":"Deramiocel (CAP-1002)","slug":"deramiocel-cap-1002","phase":"phase_3","mechanism":"Deramiocel is an allogeneic cardiosphere-derived cell therapy that promotes cardiac repair and reduces inflammation following myocardial injury.","indications":["Acute myocardial infarction with reduced ejection fraction","Duchenne muscular dystrophy-associated cardiomyopathy"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNaXdqSk43TnRKR19SMmJscXU1cU1VLU1IdHJNTGFTM25pVHN5NVpxLUZSWW5LS2xiSFJhb0hlT3ZfTFNZQ1pqS1NxSDhjVERGZUJoblBtVTkzb2kyU2JHVVNQS3dLQWlpYmVDYmlYWjNhVElYTXFLY05fNHVIdm1CRTF4Z2tNRG4xR2RzV1hENzY4MEl0VHJNTzBmcHA2UFkzUnBMSnRjbzNnUnJIZXh3MVI3UVJNSVE?oc=5","date":"2026-03-09","type":"regulatory","source":"TechStock²","summary":"Capricor Therapeutics Stock Rises Ahead of March 12 Update as FDA Watch on Duchenne Drug Builds - TechStock²","headline":"Capricor Therapeutics Stock Rises Ahead of March 12 Update as FDA Watch on Duchenne Drug Builds - TechStock²","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxQd0Jyb3lWVFlMSWtZMUNnVlVOUUdJYndUakRMdFZ4WDlVQTdHOHRzWnk2N1VOdm1RUzd2MXhpV3FDZFM5X21ORm5WSXBEU2NYMlZTdmVob19FV3hoT1NucjdvNHc5S01EbUVpNE9ucE04RHZYWkVDZFF1dlMyV1gtTkQwbElrempsNzJmeGdwSk9kbUxJVElwclJBOVFxR2gyVDU5U1NVeUQ4bVpVRXFlNzVETW8zNjIyQUZkb19Kb21EWE40NVJQY0NNRGpqTVo2Z0RvSkZfU2M4X2dTQ0txamlCQU41cTFYZS1MNVUzSVV2aUYyaHZUOUR0Y1UxaUVzY1JEbHRMNA?oc=5","date":"2026-03-05","type":"trial","source":"Stocktwits","summary":"‘Pharma Bro’ Martin Shkreli Calls His Capricor Therapeutics Short A 'Bad Call' After DMD Trial Delivers Surprise Win - Stocktwits","headline":"‘Pharma Bro’ Martin Shkreli Calls His Capricor Therapeutics Short A 'Bad Call' After DMD Trial Delivers Surprise Win","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPTlJNdmZKNU9qeFIwaXRpNExhVGJCT2NGOUVVeW54dThFSXFaTU9KM2g0d2xlQU10TzdZenFBRkJraFdJRG9wdkhNMmt3eVVEYUVfN0JUYUE1Z1M5UTB6M29xYUF2dWd1R1ByVEpnR2VCWkNCYWhOVFU3elRaM2NXa05RNXJMRjlvUnRaMVV6MGR4OXh2Mm1WRzJ6LUJDSldUYkFtSl9qa0V3cEZQLUk3OHFfZ3EwWktCRHE4?oc=5","date":"2025-12-03","type":"regulatory","source":"Seeking Alpha","summary":"Capricor Therapeutics: Shares Soaring After DMD Study Win - Ball Now In FDA's Court (CAPR) - Seeking Alpha","headline":"Capricor Therapeutics: Shares Soaring After DMD Study Win - Ball Now In FDA's Court (CAPR)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPbElZdDJYeFFOemJkalpudTNaSENoaUNLSkFrZUcwSUdNc0s0S3pnem1RVUtHUDgtdV9HeTU5UnlzRERHVTloRWhRczhLNTdxVGtaaGhYekRWVTFhMDE4bnR6LWQ3Q1oxMENLMUh2ejlVYTJTMkZQSm1Pbkl5UTNwV1kxS3p5QXctbDVmbkUwQkRxeXNXOU9NeGFiSExTdXBsZkNwNFc3M25RWS1yT3h6RTVpUnl1VkY1ZXlFSWg4Zw?oc=5","date":"2025-12-03","type":"pipeline","source":"Sahm","summary":"Capricor Stock Soars, Shkreli Is Short: Here's What Pharma Bro Had To Say - Sahm","headline":"Capricor Stock Soars, Shkreli Is Short: Here's What Pharma Bro Had To Say","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPV09fQ1V1OHNGeGRMckRFX1RKc0tmdU9Wc0F0cnZ3Y0tzVGd4Q0NtU3lwVDZadW1VQVdYbTZ6amlXWG5FWlZTdTNjOXFnb09IWlB6b1RJZmtaTDJPclFZS0RBMTdRTXBYc1kzUEZnTGhtMzV0QkNzYjUyZ3ZPT2xyWlpVWW9qbWxITGdzR2lMajdsQ1J6ZmQ1OE5PR1lVaXhkY2c?oc=5","date":"2025-12-03","type":"pipeline","source":"BioPharma Dive","summary":"Capricor soars on positive results for Duchenne cell therapy - BioPharma Dive","headline":"Capricor soars on positive results for Duchenne cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNNFpzN1BBUWhEVERvbndER1d5OExabHo3OGw0UE4xZTZidjcxWF91UXg4Q1Rya2ZkVFNSTmxKbk5ndFR5ZGthOXVNZHR4NzN5ZFdyZTlRMGlNQXhoU1ZyRXVscDdvMDRyQWxKLUl4NFNTeWctb1pydWJTbWxDdEFLZVNaaWJLN0YxSWdSVGtOUlpaX2daNG5la2tkbm4tVV95SmMwZmNVZThmVTNaNzJQS0VubEh5aEEzelZEbENRbXM0WGc?oc=5","date":"2025-11-21","type":"pipeline","source":"Stocktwits","summary":"‘Pharma Bro’ Martin Shkreli Goes Short On Capricor Therapeutics – Stock Tumbles 17% - Stocktwits","headline":"‘Pharma Bro’ Martin Shkreli Goes Short On Capricor Therapeutics – Stock Tumbles 17%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxObUlSU0o3VVE1ZEdlbkNCQ3pUbUpCbFM2YUxkN2VvM1J4a1F5MWhlZXdqd2pxNjk0Rk9ySnVVUjYzVVdjV2poUXNHVm1PVjY1aWh5dXFPWkc3b0lSQVlWbnlfR001VXozSWUzZVlzSXFTbU9WMGpTT1l1aG45SlhreEZ0MXpQb1Y5aUlBR0NlQUl4aHUyYWYwTkRNQjlid2Q5TTVTc19UR3Z5RElTRmZqZGJUQTYwV1BYQ0E?oc=5","date":"2025-10-01","type":"regulatory","source":"Streetwise Reports","summary":"Biotech Secures FDA Alignment on Late-Stage Duchenne Therapy - Streetwise Reports","headline":"Biotech Secures FDA Alignment on Late-Stage Duchenne Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNUWFIRTd0ZnZhbzZzOEY3Y0dhVDJBWHhZaWJET2hISG9jVURSWVJPenBNWmZuMUNsX3V1MzFxSWpWQUJabXZwcDhRT0Q4WGZ4UE9TYXBWSno2U0x2YlR5ZUtRSDkweVQ3TGl5eXhmVDd2dXB0emp6dk5aeEFTbFV4bm1vbC1MZ3VMNVRxdzZoZDJmTWZ4WHRtdUNueTlMVnR0RE5YYS1IUFExZVYxV1UzWTdZdFRKSldVRlNFNHVVaUE?oc=5","date":"2025-09-29","type":"regulatory","source":"Seeking Alpha","summary":"Capricor Therapeutics: A Buy Ahead Of Phase 3 Topline And Clarified Regulatory Pathway - Seeking Alpha","headline":"Capricor Therapeutics: A Buy Ahead Of Phase 3 Topline And Clarified Regulatory Pathway","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPT3REUHZ5VVBLby1aQlNmNDhLcWRRS3R4dHZzSm1KTWlOcFp6NEtWdk1hdjlGeTRwMldjd3JhNk9weXdXOFNvNUJ1WllveDhwZkVHd2hkd3pxMy1iVWNRNG1MZndtQkM1cEhaQll2em9jdjJBOFNBUTZreEhHdGxYN3pOVWMyQWdRT2d1RWxYejJIRGZrTEhnekhxb0VGTE5FLUR3TTIyeWhhNjJyTWpaZU1PRTNGUmpZbEpkOFhrRTlyMURjSmJuYg?oc=5","date":"2025-07-11","type":"regulatory","source":"Reuters","summary":"Capricor shares sink as US FDA declines to approve cell therapy - Reuters","headline":"Capricor shares sink as US FDA declines to approve cell therapy","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE10eUFPUjlPZEs4ZmFyM1FfODdZTG4yc3VDQUZNMG9MZ21CNVlSNEEzMVhyYlpRVEEzaVhXVXZCaWZjb1NBMnRMdTllaFRTc3l5cUZr?oc=5","date":"2025-07-11","type":"regulatory","source":"FirstWord Pharma","summary":"FDA rejects approval of Capricor's cell therapy for DMD - FirstWord Pharma","headline":"FDA rejects approval of Capricor's cell therapy for DMD","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNNzlheFVpSHlxQ0I2SUEtMjhDZXd0UGRVcHpqeTMtN0U2V05qTmVlLVZucE1mUlZBZUZvTnYyUUpBTGd1ZHluWmZzY29vSGliUXJYUTI3ZXFOdFVST0J0RVdKZ0c1TmFQYWtGdDkwai1RNl9lZDNnRU1SaTJRV2V2UktnNUhKNXl3cG1oVG11UnFjZ2I5LUdmYWRyTFQ2TDR6RERIbzFLckJ4TFZzbTBFV0pJNmJrUXZjNWdzUkNwZmhUVUtKMUIxSmhZdzUtZUZPRkJ5ald5VDJFRE54VnB6VA?oc=5","date":"2025-06-24","type":"regulatory","source":"Reuters","summary":"Capricor says US FDA may not convene expert panel for co's cell therapy - Reuters","headline":"Capricor says US FDA may not convene expert panel for co's cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPUjUtaDQ0Y0hFMnQtWEJMMGFlTm1iWlNyRUpOd0oxS3lqWU4yUXBYN3BTTHRvcWoxUldFTEhMVllsb1lRVDF4Rjl3Mlk0cDhRdGFZSHYxeUZqekVwb3Q1b0xCQ0Y1MFZ2ZjgyTHUwZVBxZGlKVEVvcjBPNFhFamZfV1dMbXY5ZjZnOVVuS3puWXU2RThLRWUzN1dzNzBmeGpYTTN6WV9fQlR2RGNKWnFMR1g5NEZ6MnNscTczc2V0a1o2dGRtd2Vubkk0Yl9ndFQ1ck9DU3NwTjJlS3NFQ2hnQVZROTZQQ0JWaWc?oc=5","date":"2025-03-10","type":"regulatory","source":"PR Newswire","summary":"FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment - PR Newswire","headline":"FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}